MedPath

Screening for Lung Cancer in Subjects With Family History of Lung Cancer

Recruiting
Conditions
Lung Cancer
Interventions
Diagnostic Test: Low dose CT thorax
Registration Number
NCT05762731
Lead Sponsor
The University of Hong Kong
Brief Summary

Lung cancer can be detected via screening of high-risk individuals, i.e current or ex-heavy smokers, with low-dose computer tomography (LDCT) of thorax. The National Lung Screening Trial in US and the NELSON trial in Europe demonstrated reduction in lung cancer mortality with LDCT screening for lung cancer. In Hong Kong, however, there is a prominence of female never-smokers with lung cancer. There is no identifiable risk factors for non-smokers with lung cancer except family history of lung cancer. The hypothesis is that lung cancer screening for subjects with family history of lung cancer, can detect early lung cancer.

Detailed Description

The primary aim of this prospective study is to find out the rate of lung cancer detection in subjects who are first degree relatives of lung cancer patients. Secondary aims include studying the characteristics of screen-detected lung cancer. This is a multi-centered prospective cohort study. 1,520 subjects who are first degree relatives of lung cancer patients at four public hospitals in Hong Kong will be screened. Intervention Detailed questionnaires and LDCT Thorax will be performed. The primary outcome measure is the number of lung cancers detected by this study. The screening-detection rate of lung cancer in first-degree relatives of lung cancer patients will be estimated.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1520
Inclusion Criteria
  • Age 50-75, men or women, smokers or non-smokers
  • Being first degree relatives (Siblings, children, and parents) of lung cancer subjects
  • Having no known lung cancer before
Exclusion Criteria
  • Non-Chinese
  • Mentally incompetent to give informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control groupLow dose CT thoraxNon-lung cancer subjects who are not related any lung cancer patients
First degree relatives of lung cancer patientsLow dose CT thoraxAge 50-75, men or women, smokers or non-smokers. Being first degree relatives (siblings, children and parents) of lung cancer subjects. Having no known lung cancer before.
Primary Outcome Measures
NameTimeMethod
The rate of lung cancer detection in subjects with family history of lung cancerAn average of 2.5 years

The number of screening-detected lung cancer among first degree relatives of lung cancer patients.

Secondary Outcome Measures
NameTimeMethod
The characteristics of screening detected lung cancerAn average of 2.5 years

Stage distribution of lung cancer detected.

Trial Locations

Locations (1)

University of Hong Kong

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath